[ET Net News Agency, 25 June 2024] JD HEALTH (06618) fell 3.2% to HK$22.4.
It hits an intra-day low of HK$22.3, hitting a historical low, and an intra-day high of
HK$23.5. The total shares traded was 4.91 million, with a value of HK$112.69m. The active
buy/sell ratio is 40:60, with net selling turnover of HK$21.01m. CHINA INNOVATION MARKET
SER accounts for greatest net responsive buying turnover of HK$7.39m, with volume weighted
average price of HK$22.888. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive
selling turnover of HK$3.4m, with volume weighted average price of HK$22.818. The stock
has fallen a combined 9.9% over the past 4 consecutive trading days.
RMB counter of JD HEALTH (86618) fell 3% to RMB20.9. It hits an intra-day low of RMB21,
and an intra-day high of RMB21.7. The total shares traded was 1,050, with a value of
RMB22,260.
The Hang Seng Index now fell 32 points, or 0.2% to 17,995; the Hang Seng China
Enterprises Index now fell 6 points, or less than 0.1% to 6,434; the Hang Seng TECH Index
now fell 47 points, or 1.3% to 3,629.

Basic Information
=================

----------------------------------
Nominal 22.400 % Chg -3.24%
High 23.500 Low 22.300
Shares Tr 4.91m Turnover 112.69m
10-D SMA 24.025 %H.V 40.151
20-D SMA 25.255 VWAP 22.936
50-D SMA 26.503 RSI14 28.831
----------------------------------
Status: Hitting a historical low, active buy/sell ratio is 40:60, with net selling
turnover of HK$21.01m, falling a combined 9.9% over the past 4 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
JD HEALTH (06618) 22.40 -3.24
ALI HEALTH (00241) 3.28 -4.93
TRAD CHI MED (00570) 4.18 -0.71
CSPC PHARMA (01093) 6.34 +0.48
SINOPHARM (01099) 21.30 -0.93
SINO BIOPHARM (01177) 2.65 +1.92
CHINARES PHARMA (03320) 5.87 +1.03
HANSOH PHARMA (03692) 16.56 +3.24
GOLDEN THROAT (06896) 3.22 -0.92
JD HEALTH-R (86618) RMB20.90 -3.02
-----------------------------------------------
(ed)